What question did this study set out to answer?

The aim is to evaluate the effectiveness of a molecular diagnostic kit for detecting H. pylori in patients receiving PPIs and P-CABs.

March 16, 2026Open Access

Usefulness of Molecular Diagnostic Kits for Detecting Helicobacter pylori Infection in Patients Receiving Proton Pump Inhibitors and Potassium‐Competitive Acid Blockers

Key Points

The aim is to evaluate the effectiveness of a molecular diagnostic kit for detecting H. pylori in patients receiving PPIs and P-CABs.
Used Smart Gene molecular diagnostic test with intragastric fluid sample.
Assessed patients on PPI/P-CAB therapy for gastrointestinal symptoms.
Tested for H. pylori infection and CAM-resistance mutations.
Test confirmed H. pylori infection within 1 hour of testing.
Identified CAM-resistance mutations in the same timeframe.
May help reduce side effects from unnecessary eradication therapy.

Abstract

The Smart Gene molecular diagnostic test using intragastric fluid was useful for patients requiring PPI/P-CAB to manage gastrointestinal symptoms. It could also confirm an H. pylori infection and CAM-resistance mutations within 1 h of testing. This diagnostic test may help reduce side effects and the emergence of resistant strains due to unnecessary eradication therapy.

Read Full Paperexternally

Bookmark

View Full Paper

Cite This Study

Wakamatsu et al. (Thu,) studied this question.

synapsesocial.com/papers/69b79e7c8166e15b153abe31 https://doi.org/https://doi.org/10.1155/bmri/2610573

Bookmark

View Full Paper